Victoria House has been officially opened in London’s Bloomsbury Square as the capital’s state-of-the-art life sciences hub.

The building was opened on Tuesday at a launch event which brought together leaders from science, academia, venture capital and the UK parliament. It is hoped Victoria House can help the UK achieve its ambition to become a global leader in scientific innovation and commercialisation.

The 300,000 square feet facility offers a unique combination of lab-enabled, fully fitted and incubator laboratory space and serviced offices within highly technical, tailored infrastructure. The facility will support the full lifecycle of life sciences companies as well as multinational pharmaceutical and biotechnology businesses, academic research institutions, government agencies, and venture capital firms.

James Boadle, Managing Director, Europe, Oxford Properties, commented: “Victoria House is a unique Art Deco building and a superb example of how heritage properties can be reimagined to meet modern day requirements and standards of sustainability. The UK remains a world leader in life sciences and, building on its long track record of supporting experimentation, discovery and breakthroughs, the sector will continue to grow.”

“With Victoria House, we’ve built an ecosystem engineered for rapid growth, capital efficiency, and connection.” said Richard O’Boyle, Chief Executive of Pioneer Group. “It’s about enabling scientists and entrepreneurs to scale faster, smarter, and in a space that inspires innovation. Centrally located and purposefully designed with future growth, Victoria House offers the expansion space needed to support large-scale experimental work in AI and drug development.”

‘A brilliant opportunity’

 Victoria House is the first location in London to combine incubator labs with fully serviced office space in a Grade II listed building, specifically tailored for life sciences. The fourth floor is already home to nine digital health and AI-driven research start-ups including Deep Mirror, Caerulus Genomics, Neurocentrx, M2M Bio, and Forcefield Therapeutics, as well as clinical-stage biotech AAVantgarde Bio. 

Residents in the incubator labs on the seventh floor include four early-stage companies – Xterna, AAVantgarde Bio, Curecraft, and Emles Bioventures – spanning research in cancer therapies, therapeutic proteins and next-generation health tech.  

The building is also home to the BioIndustry Association (BIA), which established its UK headquarters at Victoria House last year. 

Steve Bates, CEO of the BIA, said: “Victoria House is at the heart of the UK’s vibrant life science innovation ecosystem. It’s proved a fantastic home for the BIA from serendipitous meetings with key ecosystem players to the ability to utilise impressive board meeting rooms. The central location makes for easy connections across the UK, with global pharma, tech bio start-ups, universities and policymakers all in easy distance.” 

Dr Jess Corry, CEO and co-founder of biotech start-up Xterna, one of the first businesses to move into Victoria House’s incubator labs, said: “It has been a brilliant opportunity to be the first in. We have been able to help shape the space to our needs, and the flexibility has been invaluable. One of the biggest advantages is access to core facilities. Victoria House offers shared equipment like confocal microscopes and flow cytometers, which would be prohibitively expensive for us to purchase outright. That’s a game-changer for an early-stage company where every penny counts. The building itself is also beautiful – very different from a typical lab environment – it’s a talking point for attracting talent.”